FMC Corporation Secures $400 Million Investment from Tessenderlo Group to Pay Down Debt

FMC Corporation (NYSE: FMC) has struck a $400 million deal with Belgium's Tessenderlo Group (XBRU: TESB), giving the Belgian industrial company a 20% stake in the American agricultural sciences firm, according to PR Newswire. The agreement, announced June 30, marks the end of a five-month strategic review that had openly considered a full sale of the company.
FMC will use the cash to pay down debt. The company has been under severe financial pressure, carrying $4.5 billion in gross debt and a credit rating that fell to junk status in late 2025, StreetInsider reported. The deal price of $13.30 per share values FMC well below its 52-week high of $44.68.
The Tessenderlo investment is the capstone of a frantic year of deal-making by FMC. Earlier in 2026, the company sold its India commercial business to Crystal Crop Protection for $252 million and signed a 10-year license deal with Corteva Inc. that brought in a $200 million upfront payment, according to PR Newswire. A sale-and-leaseback of FMC's Newark, Delaware property added another $114 million.
Together, those moves plus the $400 million from Tessenderlo push FMC to its target of roughly $1 billion in debt reduction for 2026, per Investing.com. The company also refinanced existing debt in June with $1.2 billion in senior secured notes at 8.0% interest. CEO Pierre Brondeau called the Tessenderlo agreement "the best path forward for our company and its shareholders."
FMC's board authorized a full strategic review in February 2026, openly putting the company up for consideration. The firm had lost nearly 90% of its equity value over five years. A 29% sales drop in late 2023 triggered shareholder lawsuits alleging the company had inflated sales figures through "channel stuffing," according to StreetInsider. Ratings agencies S&P and Fitch cut FMC's credit to speculative grade, commonly called junk, in late 2025.
Rather than sell the entire company, the board chose the minority investment route. That decision keeps FMC listed on the NYSE as an independent company. BMO Capital Markets had rated FMC as Outperform, pointing to the company's asset sale plans as the clearest path to recovery, Investing.com noted.
Tessenderlo Group is a Belgian industrial company led by CEO Luc Tack, who is also its controlling shareholder. Its agricultural arm, Tessenderlo Kerley, focuses on specialty fertilizers and crop protection products. Tack said the FMC investment fits his plan to "expand our agro platform through strategic cornerstone investments" and praised FMC's proprietary crop molecules for their "meaningful long-term potential," according to PR Newswire.
Belgian business media frame the deal differently than US outlets do. Tack has a history of entering companies as a minority investor and then seeking deeper control over time, as he did with Picanol Group over several years, Barchart reported. Some analysts see the 20% stake as a first step toward a larger role in FMC's future rather than a passive financial bet.
Existing FMC shareholders will own a smaller slice of the company once Tessenderlo's 20% stake is issued. That dilution is a clear downside of the deal. FMC's stock had already fallen sharply, dropping out of the Russell 1000 index and into the smaller Russell 2000 in June 2026, a signal of how far the company's market value had shrunk, according to Yahoo Finance.
Bulls point to FMC's pipeline of new active ingredients, which the company values at roughly $2 billion. The Q1 2026 results beat analyst estimates with $759 million in revenue, and FMC reaffirmed its full-year debt targets, per Investing.com. The deal still needs regulatory approval before it closes. If it does, FMC's net leverage ratio — now at 5.7x — should drop meaningfully by year end.
Publishers
8
Articles
7
Reach
8